1,2-dimethylhydrazine increases expression ISO RGD:1315558 6480464 1, 2-Dimethylhydrazine results in increased expression of RNF125 mRNA CTD PMID:22206623 17beta-estradiol decreases expression ISO RGD:1315557 6480464 Estradiol results in decreased expression of RNF125 mRNA CTD PMID:20106945 17beta-estradiol multiple interactions ISO RGD:1315557 6480464 [Estradiol co-treated with Progesterone] results in increased expression of RNF125 mRNA, [Estradiol co-treated with TGFB1 protein] results in decreased expression of RNF125 mRNA CTD PMID:20660070 , PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of RNF125 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1315558 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of RNF125 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1315558 6480464 Tetrachlorodibenzodioxin affects the expression of RNF125 mRNA CTD PMID:16962184 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of RNF125 mRNA CTD PMID:21215274 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of RNF125 mRNA CTD PMID:21346803 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of RNF125 mRNA CTD PMID:30071829 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of RNF125 mRNA CTD PMID:28522335 4-hydroxyphenyl retinamide increases expression ISO RGD:1315558 6480464 Fenretinide results in increased expression of RNF125 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of RNF125 mRNA CTD PMID:24780913 acrylamide decreases expression ISO RGD:1315558 6480464 Acrylamide results in decreased expression of RNF125 mRNA CTD PMID:30807115 aflatoxin B1 affects expression ISO RGD:1315557 6480464 Aflatoxin B1 affects the expression of RNF125 protein CTD PMID:20106945 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of RNF125 mRNA CTD PMID:30779732 arsane affects methylation ISO RGD:1315557 6480464 Arsenic affects the methylation of RNF125 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1315557 6480464 Arsenic affects the methylation of RNF125 gene CTD PMID:25304211 benzo[a]pyrene decreases expression ISO RGD:1315557 6480464 Benzoapyrene results in decreased expression of RNF125 mRNA CTD PMID:20106945 , PMID:32234424 benzo[a]pyrene decreases methylation ISO RGD:1315557 6480464 Benzoapyrene results in decreased methylation of RNF125 promoter CTD PMID:27901495 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1315558 6480464 Diethylhexyl Phthalate results in increased expression of RNF125 mRNA CTD PMID:19850644 , PMID:21318169 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1315558 6480464 PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in increased expression of RNF125 mRNA] CTD PMID:19850644 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of RNF125 mRNA CTD PMID:25181051 , PMID:30903817 bisphenol A decreases expression ISO RGD:1315557 6480464 bisphenol A results in decreased expression of RNF125 mRNA CTD PMID:31715268 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of RNF125 gene CTD PMID:28505145 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Genistein] results in decreased methylation of RNF125 gene CTD PMID:28505145 bisphenol A decreases methylation EXP 6480464 bisphenol A results in decreased methylation of RNF125 gene CTD PMID:28505145 bisphenol A decreases expression ISO RGD:1315558 6480464 bisphenol A results in decreased expression of RNF125 mRNA CTD PMID:25594700 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of RNF125 mRNA CTD PMID:24136188 captan decreases expression ISO RGD:1315558 6480464 Captan results in decreased expression of RNF125 mRNA CTD PMID:31558096 carbon nanotube affects expression ISO RGD:1315558 6480464 Nanotubes, Carbon affects the expression of RNF125 mRNA CTD PMID:25620056 carbon nanotube decreases expression ISO RGD:1315558 6480464 Nanotubes, Carbon analog results in decreased expression of RNF125 mRNA CTD PMID:25620056 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of RNF125 mRNA CTD PMID:24386269 cyclosporin A decreases expression ISO RGD:1315557 6480464 Cyclosporine results in decreased expression of RNF125 mRNA CTD PMID:20106945 cyclosporin A increases expression ISO RGD:1315557 6480464 Cyclosporine results in increased expression of RNF125 mRNA CTD PMID:27989131 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of RNF125 mRNA CTD PMID:23640034 dibenz[a,h]anthracene decreases expression ISO RGD:1315558 6480464 1 more ... CTD PMID:26377693 dorsomorphin multiple interactions ISO RGD:1315557 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 fenofibrate increases expression ISO RGD:1315558 6480464 Fenofibrate results in increased expression of RNF125 mRNA CTD PMID:21318169 fluoranthene multiple interactions ISO RGD:1315558 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of RNF125 mRNA CTD PMID:28329830 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of RNF125 mRNA CTD PMID:24136188 folpet decreases expression ISO RGD:1315558 6480464 folpet results in decreased expression of RNF125 mRNA CTD PMID:31558096 furan increases methylation EXP 6480464 furan results in increased methylation of RNF125 gene CTD PMID:22079235 furan decreases expression EXP 6480464 furan results in decreased expression of RNF125 mRNA CTD PMID:26194646 gadodiamide hydrate increases expression ISO RGD:1315557 6480464 gadodiamide results in increased expression of RNF125 mRNA CTD PMID:20959327 genistein multiple interactions EXP 6480464 [bisphenol A co-treated with Genistein] results in decreased methylation of RNF125 gene CTD PMID:28505145 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of RNF125 mRNA CTD PMID:22061828 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of RNF125 mRNA CTD PMID:24136188 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RNF125 mRNA CTD PMID:22129741 lipopolysaccharide decreases expression ISO RGD:1315558 6480464 Lipopolysaccharides results in decreased expression of RNF125 mRNA CTD PMID:27339419 MeIQx increases expression ISO RGD:1315557 6480464 2-amino-3 more ... CTD PMID:20816883 mercury dibromide decreases expression ISO RGD:1315557 6480464 mercuric bromide results in decreased expression of RNF125 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1315557 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of RNF125 mRNA CTD PMID:27188386 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of RNF125 mRNA CTD PMID:30467583 methotrexate affects expression ISO RGD:1315558 6480464 Methotrexate affects the expression of RNF125 mRNA CTD PMID:18502557 methyl methanesulfonate decreases expression ISO RGD:1315557 6480464 Methyl Methanesulfonate results in decreased expression of RNF125 mRNA CTD PMID:23649840 N-acetyl-L-cysteine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RNF125 mRNA CTD PMID:22129741 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1315557 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of RNF125 mRNA CTD PMID:24810058 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of RNF125 mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RNF125 mRNA CTD PMID:22129741 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of RNF125 mRNA CTD PMID:24136188 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of RNF125 mRNA CTD PMID:24136188 O-methyleugenol decreases expression ISO RGD:1315557 6480464 methyleugenol results in decreased expression of RNF125 mRNA CTD PMID:32234424 p-chloromercuribenzoic acid decreases expression ISO RGD:1315557 6480464 p-Chloromercuribenzoic Acid results in decreased expression of RNF125 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1315557 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of RNF125 mRNA CTD PMID:27188386 paracetamol affects expression ISO RGD:1315558 6480464 Acetaminophen affects the expression of RNF125 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1315557 6480464 Acetaminophen results in decreased expression of RNF125 mRNA CTD PMID:29067470 paracetamol multiple interactions ISO RGD:1315558 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in decreased expression of RNF125 mRNA] CTD PMID:29246445 paracetamol decreases expression ISO RGD:1315558 6480464 Acetaminophen results in decreased expression of RNF125 mRNA CTD PMID:29246445 paracetamol affects response to substance ISO RGD:1315557 6480464 RNF125 gene polymorphism affects the susceptibility to Acetaminophen CTD PMID:26104854 perfluorooctanoic acid decreases expression ISO RGD:1315557 6480464 perfluorooctanoic acid results in decreased expression of RNF125 mRNA CTD PMID:32588087 phenobarbital affects expression ISO RGD:1315558 6480464 Phenobarbital affects the expression of RNF125 mRNA CTD PMID:23091169 phenobarbital decreases expression ISO RGD:1315558 6480464 Phenobarbital results in decreased expression of RNF125 mRNA CTD PMID:19270015 phenylmercury acetate decreases expression ISO RGD:1315557 6480464 Phenylmercuric Acetate results in decreased expression of RNF125 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1315557 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of RNF125 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:1315558 6480464 [PPARA protein affects the susceptibility to pirinixic acid] which affects the expression of RNF125 mRNA CTD PMID:21318169 pirinixic acid increases expression ISO RGD:1315558 6480464 pirinixic acid results in increased expression of RNF125 mRNA CTD PMID:18301758 , PMID:23811191 potassium chromate increases expression ISO RGD:1315557 6480464 potassium chromateVI results in increased expression of RNF125 mRNA CTD PMID:22714537 progesterone multiple interactions ISO RGD:1315557 6480464 [Estradiol co-treated with Progesterone] results in increased expression of RNF125 mRNA CTD PMID:20660070 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of RNF125 mRNA CTD PMID:28374803 rotenone decreases expression ISO RGD:1315557 6480464 Rotenone results in decreased expression of RNF125 mRNA CTD PMID:29955902 SB 431542 multiple interactions ISO RGD:1315557 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 silver atom decreases expression ISO RGD:1315558 6480464 Silver results in decreased expression of RNF125 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1315558 6480464 Silver results in decreased expression of RNF125 mRNA CTD PMID:27131904 sodium arsenite decreases expression ISO RGD:1315557 6480464 sodium arsenite results in decreased expression of RNF125 mRNA CTD PMID:29301061 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of RNF125 mRNA CTD PMID:25993096 sunitinib increases expression ISO RGD:1315557 6480464 Sunitinib results in increased expression of RNF125 mRNA CTD PMID:31533062 tetrachloromethane decreases expression ISO RGD:1315558 6480464 Carbon Tetrachloride results in decreased expression of RNF125 mRNA CTD PMID:27339419 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of RNF125 mRNA CTD PMID:31150632 triclosan decreases expression ISO RGD:1315557 6480464 Triclosan results in decreased expression of RNF125 mRNA CTD PMID:30510588 valproic acid affects expression ISO RGD:1315558 6480464 Valproic Acid affects the expression of RNF125 mRNA CTD PMID:17292431 valproic acid decreases expression ISO RGD:1315557 6480464 Valproic Acid results in decreased expression of RNF125 mRNA CTD PMID:28001369 valproic acid affects expression ISO RGD:1315557 6480464 Valproic Acid affects the expression of RNF125 mRNA CTD PMID:25979313 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of RNF125 mRNA CTD PMID:23034163